Acerus to Report 2020 Financial Results and Host Investor Call
Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will
announce its fourth quarter and full year 2020 financial and
operating results on Thursday, March 11, 2021 before the market
opens. The company will host a conference call on Thursday, March
11, 2021 at 10:00 a.m. Eastern Time.
To access the call live, please dial
416-406-0743 or 1-800-952-5114 and use access code 4028136#.
Listeners are encouraged to dial in 10 minutes before the call
begins to avoid delays. A replay of the conference call will be
available until 11:59 p.m. Eastern Time on Thursday, March 18, 2021
by dialing 905-694-9451 or 1-800-408-3053, using access
Acerus Pharmaceuticals Corporation is a
Canadian-based specialty pharmaceutical company focused on the
commercialization and development of innovative prescription
products that improve patient experience, with a primary focus in
the field of men’s health. The Company commercializes its products
via its own salesforce in the United States and Canada, and through
a global network of licensed distributors in other territories.
Acerus’ shares trade on TSX under the symbol ASP
and on OTCQB under the symbol ASPCF. For more information,
visit www.aceruspharma.com and follow us
on Twitter and LinkedIn.
Investor Relations ContactChris WittyAcerus
Investor Relations (646) firstname.lastname@example.org